Life ScienceCompany
Cormorant Pharmaceuticals AB Ownership
Who owns Cormorant Pharmaceuticals AB?
Cormorant Pharmaceuticals AB is owned by Bristol-Myers Squibb. It was acquired on July 5, 2016.
Cormorant Pharmaceuticals AB Business Overview
Where is Cormorant Pharmaceuticals AB headquartered?
Cormorant Pharmaceuticals AB is headquartered in Sweden.
What sector is Cormorant Pharmaceuticals AB in?
Cormorant Pharmaceuticals AB is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.